Abstract: A main body controller provided in an image forming apparatus receives a VDP job from an external computer, and arranges image data of a reusable object and a variable object, which correspond to the VDP job, on a page for printout. An inspection controller performs inspection processing for printed matter for each page, and the main body controller preferentially stores image data of the reusable object, which corresponds to the page for which the printing has been determined to be defective as a result of inspection processing, in a cache unit. The main body controller acquires the reusable object, which corresponds to the page for which the printing has been determined to be defective, from the cache unit, and executes page reprint processing using the acquired reusable object.

Abstract: An iris authentication apparatus includes an iris area extraction unit, registration pattern generating unit, collation pattern generating unit, and collation unit. The iris area extraction unit extracts iris areas from a sensed registration eyeball image and a sensed collation eyeball image. When the iris area extraction unit extracts an iris area from the registration eyeball image, the registration pattern generating unit generates a registration iris pattern image by performing polar coordinate transformation of an image in the extracted iris area. When the iris area extraction unit extracts an iris area from the collation eyeball image, the collation pattern generating unit generates a collation iris pattern image by performing polar coordinate transformation of an image in the extracted iris area.

Abstract: A current sensing circuit can prevent operation error due to a rush current and/or a shifted sense ratio. The circuit includes a power MOSFET, a series combination of a sense resistor and a sense MOSFET, which are connected in parallel to the power MOSFET Qph, a delay circuit for delaying the edges of drive signal, by first delay time, a delay circuit for delaying the edges of the drive signal by a second delay time, logic for combining signals and a current sensing circuit for sensing an electric current of the sense MOSFET based on an electric current of the sense resistor.

Abstract: It is possible to commercially advantageously prepare 1-{1-[2-(7-methoxy-2,2-dimethyl-4-oxochroman-8-y)ethyl]piperidin-4-yl}-N-methyl-1H-indole-6-carboxamide by coupling (7-methoxy-2,2-dimethyl-4-oxochroman-8-yl)acetaldehyde, which is obtained by oxidizing 8-(2-hydroxyethyl)-7-methoxy-2,2-dimethylchroman-4-one, with N-methyl-1-(piperidin-4-yl)-1H-indole-6-carboxamide.

Abstract: A honeycomb structure comprising porous partition walls which form, by surrounding, a plurality of cells extending between the two ends faces of the honeycomb structure, and an outer wall formed integrally with the partition walls. The cells consist of partial cells of outermost peripheral portion, having incomplete cell sections, which are located at the outermost peripheral portion of the honeycomb structure and are in partial contact with the outer wall, and complete cells having a complete cell section, other than the partial cells of outermost peripheral portion. In the complete cells, a plugged part is formed at one end of each complete cell so that each end face of the honeycomb structure shows a checkerwise plugging pattern. In the partial cells of outermost peripheral portion to be plugged according to the above-mentioned plugging pattern, part of them is plugged in the entire length and formed integrally with the outer wall and remaining cells have each a plugged part only at one end.

Abstract: The present invention relates to a novel two cyclic cinnamide compound and a pharmaceutical agent comprising the compound as an active ingredient. The two cyclic cinnamide compound represented by the general formula (I): wherein represents a single bond or a double bond; Ar1 represents a phenyl group or pyridinyl group that may be substituted with 1 to 3 substituents; R1 and R2 each represent a C1-6 alkyl group, a hydroxyl group, or the like; Z1 represents a methylene group or vinylene group, which may be substituted with 1 or 2 substituents selected from Substituent Group A1, an oxygen atom, or an imino group that may be substituted with a substituent selected from Substituent Group A1; and p, q, and r each represent an integer of 0 to 2, which has an effect of reducing A?40 and A?42 production, and thus is particularly useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by A? such as Alzheimer's disease or Down's syndrome.

Abstract: A system for comparing dental X-ray images includes a positional displacement calculator calculating a positional displacement between dental X-ray test and reference images by using phase-only correlation, a positional displacement corrector correcting the positional displacement, a base point extractor defining, as a base image, any one of the dental X-ray test and reference images, and defining, as a corresponding image, the other one of the two dental images, and extracting base points from the base image, a corresponding point extractor extracting corresponding points, which correspond to the base points, from the corresponding image, a correspondence calculator calculating correspondence between the base points and the corresponding points, a nonlinear distortion corrector correcting a nonlinear distortion between the base image and the corresponding image, based on the correspondence, and a similarity calculator finding, by using phase-only correlation, a similarity between the base image and the corre

Abstract: A switching DC-DC converter includes: an output voltage detecting unit configured to detect a DC output voltage; an error amplifying unit configured to compare the detected output voltage and a reference voltage and configured to supply an amplified error signal between the detected output voltage and the reference voltage to the pulse width modulating unit; and a single oscillating unit connected to an output of the output voltage detecting unit and an output of the error amplifying unit and operable on a first oscillating mode and a second oscillation mode. The oscillating unit on the first oscillating mode controls a switching frequency of the power switch based on the detected output voltage. The oscillating unit on the second oscillating mode controls the switching frequency of the power switch based on the amplified error signal.

Abstract: The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.

Abstract: A method of manufacturing a plugged honeycomb structure has a plugging process which includes the steps of: immersing one end (a first end) of a honeycomb base material in a plugging slurry while vibrating the plugging slurry; after bringing an internal part of a cell into a negative pressure and then returning it into an atmospheric pressure, vibrating the plugging slurry to make the plugging slurry enter a first open end of the cell; and drying the plugging slurry having entered the first open end of the cell to form a first plugging portion at the first end.

Abstract: A manufacturing method of a plugged honeycomb structure including attaching a transparent sheet to an end face of a honeycomb structure; picking up an image of the end face; with respect to cells positioned at other than outermost peripheral portion of a honeycomb structure (usual cells), subjecting the picked-up image to image processing, recognizing positions to be plugged on said sheet, and with respect to cells positioned at outermost peripheral portion (outermost peripheral cells), positions of the cells are recognized based on an average cell pitch calculated from the positions of the cells, subjecting to a perforation treatment based on the recognized positions of the sheet, submerging an end portion into a plugging slurry in which a material of the plugging portions is slurried, filling holes made at the respective sheet with the slurry to form the plugging portions.

Abstract: There is provided a honeycomb structure including: porous partition walls separating and forming a plurality of cells extending between two end faces, and an outer peripheral wall formed unitarily with the partition walls. The cells include outermost peripheral portion partial cells each locating in an outermost peripheral portion of the honeycomb structure and having an incomplete cell cross section, a part of which is brought into contact with the outer peripheral wall, and complete cells each having a complete cell cross section other than the outermost peripheral portion partial cells. The complete cells and the outermost peripheral portion partial cells having plugging portions formed on one end portion so that an entire end face of the honeycomb structure shows a checkerwise plugging pattern, and the depth of the plugging portions in the outermost peripheral partial cells is smaller than that of the plugging portions in the complete cells.

Abstract: The present invention provides a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar1 represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, Ar2 represents a phenyl group that may be substituted with a C1-6 alkoxy group, or the like, X1 represents a double bond or the like, and Het represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, which is effective as a therapeutic or prophylactic agent for a disease caused by A?.

Abstract: An air conditioning apparatus has a case, a heat exchanger rotatable about a rotation axis in the case, and a pipe unit in communication with the heat exchanger. The pipe unit has a first section fixed to the case and a second section coaxially coupled to the first section. The second section is coupled to the heat exchanger and rotatable with the heat exchanger. The first section has a first annular portion, a second annular portion, a cylindrical portion, and a support member. The second section has a flange portion disposed between the first annular portion and the support member. An O-ring is disposed in a groove provided by the first annular portion and the cylindrical portion, and is in contact with a surface of the first annular portion and the flange portion in a direction parallel to the rotation axis.

Abstract: If a print misregistration amount on a sheet is larger than a predetermined threshold before determining whether a printed image is appropriate or not, an abnormal status of the image printed on the sheet is detected without correcting image data for inspection. A control method for controlling a detecting apparatus for inspecting a print status of an image printed on a sheet by a printing apparatus includes detecting, in a case where it is determined that a print misregistration amount of the image printed on the sheet with respect to the sheet is larger than a predetermined threshold, an abnormality of the print status of the image read by a reading unit without performing correction.

Abstract: The present invention provides a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar1 represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, Ar2 represents a phenyl group that may be substituted with a C1-6 alkoxy group, or the like, X1 represents a double bond or the like, and Het represents an imidazolyl group that may be substituted with a C1-6 alkyl group, or the like, which is effective as a therapeutic or prophylactic agent for a disease caused by A?.

Abstract: The present invention provides a novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. In the formula, Q indicates NH, O or S; and R1, R2, R3, R4 and R5 are the same as or different from each other and each indicates hydrogen atom, a halogen atom, a C1-6 alkyl group or a group represented by the formula —X-A (wherein X indicates a single bond, an optionally substituted C1-6 alkylene group etc.; and A indicates an optionally substituted C6-14 aromatic hydrocarbocyclic group or 5- to 14-membered aromatic heterocyclic group etc.).

Abstract: A compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar1 represents an imidazolyl group or the like which may be substituted with a C1-6 alkyl group, Ar2 represents a phenyl group or the like which may be substituted with a C1-6 alkoxy group, X1 represents a double bond or the like and Het represents a triazolyl group or the like which may be substituted with a C1-6 alkyl group or the like, is effective as a therapeutic or prophylactic agent for a disease caused by A?.

Abstract: A compound represented by Formula (I) is provided: wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar2 represents a phenyl group which may be substituted with 1 to 3 substituents; X1 represents (1) —C?C— or (2) a double bond etc., which may be substituted; R1 and R2 represent, for example, a C1-6 alkyl group which may be substituted, or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents.